| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | ABB Electrification: New 34.5kV HiPerGuard UPS: direct grid connection cuts AI data center power costs | ||
| Di | Embecta Corp.: embecta to Report Fiscal Second Quarter Financial Results | ||
| Di | LGI Homes, Inc.: LGI Homes Introduces New Community to the Growing Polk County, Florida Market | ||
| Di | NowVertical Group Inc: NowVertical Group Wins 2026 Google Cloud Data & Analytics Partner of the Year for Latin America | ||
| Di | Aktis Oncology Inc.: Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting | ||
| Di | Greenlane Holdings, Inc.: Greenlane Holdings Announces Upcoming Pre-Funded Warrant Conversion and Lock-Up of Strategic Advisor Warrants | ||
| Di | Motorsport Games Inc.: Motorsport Games Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum | ||
| Di | Toll Brothers, Inc.: Toll Brothers to Acquire Private Home Builder in Northwest Arkansas | ||
| Di | Telix Pharmaceuticals Limited: ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026 | ||
| Di | Ascendis Pharma: Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028 | ||
| Di | HCI Group, Inc.: HCI Group Sets 2026 Annual Shareholders Meeting and Record Date | ||
| Di | Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting | ||
| Di | Rapport Therapeutics, Inc.: Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting | ||
| Di | Zscaler, Inc.: Zscaler Wins 2026 Google Cloud Partner of the Year Award for Security in the Application Category | ||
| Di | ARMOUR Residential REIT, Inc. Announces May 2026 Dividend Rate Per Common Share | ||
| Di | ARMOUR Residential REIT, Inc. First Quarter 2026 Webcast Scheduled for April 23, 2026 | ||
| Di | DHT Holdings, Inc. to announce first quarter 2026 results on Tuesday, May 5, 2026 | ||
| Di | Autolus Therapeutics plc: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Di | Firefly Aerospace to Announce First Quarter 2026 Financial Results on May 4, 2026 | ||
| Di | TELA Bio, Inc.: TELA Bio to Announce First Quarter 2026 Financial Results | ||
| Di | Foghorn Therapeutics, Inc.: Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting | ||
| Di | AvePoint, Inc.: AvePoint to Announce First Quarter 2026 Financial Results on May 7 | ||
| Di | Oculis Holding AG: Oculis Publishes Invitation to the Annual General Meeting | ||
| Di | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | ||
| Di | Beeline Holdings Inc.: Beeline to Host Stakeholder Update Call on Q1 2026 Financial Results |